MIM
IRON icon

Monashee Investment Management’s Disc Medicine IRON Stock Holding History

Monashee Investment Management’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-45,000
Closed -$2M – 86
2023
Q2 		$2M Buy
+45,000
New +$1.6M 0.48% 38
2021
Q2 		– Sell
-3,915
Closed -$1.59M – 447
2021
Q1 		$1.59M Buy
+3,915
New +$1.75M 0.24% 121

Other funds holding IRON

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Monashee Investment Management's IRON Position: Q3 2023 in Review

Monashee Investment Management sold out of Disc Medicine (IRON) in Q3 2023, closing a stake of 45,000 shares — an estimated $2M sold.

Monashee Investment Management first reported a position in IRON in Q1 2021 and held it in 2 quarters. The position peaked at $2M in Q2 2023. 91 funds tracked by Wall St. Rank hold IRON as of Q3 2023.

  • Monashee Investment Management reported no remaining Disc Medicine position as of Q3 2023 after selling out during the quarter.
  • Monashee Investment Management sold 45,000 Disc Medicine shares in Q3 2023, an estimated $2M.
  • Monashee Investment Management first reported a position in Disc Medicine in Q1 2021 and held it in 2 quarters.
  • Monashee Investment Management's Disc Medicine position peaked at $2M in Q2 2023.
  • 91 funds tracked by Wall St. Rank held Disc Medicine as of Q3 2023.

Based on Monashee Investment Management's 13F filing for Q3 2023, filed 13 Nov 2023.